Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis-Reference-Cited by-同舟云学术

Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis

Published:2022-04-26 Issue:5 Volume:1 Page:
ISSN:2766-5526
Container-title:NEJM Evidence
language:en
Short-container-title:NEJM Evidence

Author:

Vu Tuan¹,Meisel Andreas²,Mantegazza Renato³,Annane Djillali⁴,Katsuno Masahisa⁵,Aguzzi Rasha⁶,Enayetallah Ahmed⁶,Beasley Kathleen N.⁶,Rampal Nishi⁶,Howard James F.⁷

Affiliation:

1. University of South Florida Morsani College of Medicine, Tampa

2. Charité–Universitätsmedizin Berlin, Berlin

3. Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologico Carlo Besta, Milan

4. Hôpital Raymond Poincaré, University of Versailles, Garches, France

5. Nagoya University Graduate School of Medicine, Nagoya, Japan

6. Alexion, AstraZeneca Rare Disease, Boston

7. The University of North Carolina, Chapel Hill

Publisher

Massachusetts Medical Society

Reference46 articles.

1. Myasthenia gravis

2. Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations

3. Myasthenia gravis: the role of complement at the neuromuscular junction

4. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society

5. Understanding side effects of therapy for myasthenia gravis and their impact on daily life

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement system activation: bridging physiology, pathophysiology, and therapy;Intensive Care Medicine;2024-09-10

2. From traditional to targeted: the changing trajectory of therapies in dermatomyositis;Current Opinion in Rheumatology;2024-08-14

3. Myasthenia gravis - diagnostischer Workup und neue Therapien;DNP – Die Neurologie & Psychiatrie;2024-08

4. Azathioprine and mycophenolate mofetil in myasthenia gravis – Authors' reply;The Lancet Neurology;2024-08

5. United States clinical practice experience with eculizumab in myasthenia gravis: symptoms, function, and immunosuppressant therapy use;Journal of Neurology;2024-07-25